A 2018 study showed that, for patients with schizophrenia, adding CBD to ongoing antipsychotic treatment reduced psychotic activity, as compared to placebo add-on
View this review (yellow link) or download:
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia- A Multicenter Randomized Controlled TrialDownload
This paper is also stored here: http://bit.ly/2WztI04 inside the CED Foundation Archive
To explore related information, click keywords below: